Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06569680
Title Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Izidore Lossos, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Miami Miami Florida 33136 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field